Quantitative Study of Spongiform Change in Putamen of 24 Cases of Creutzfeldt-Jakob Disease

Journal of Neuropathology and Experimental Neurology

Volumn 63, Issue 3, 2004, Pages 193-198

  Truchot, Lydie ^a   Bencsik, Anna ^b   Perret Liaudet, Armand ^a   Biacabe, Anne Gaëlle ^b   Richard, Marlène ^a   Ironside, James ^c   Kopp, Nicolas ^a   Streichenberger, Nathalie ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

^b Healthy Pigs Production and Experimentation Section   (France)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Creutzfeldt Jakob disease; Prion disease; Putamen; Quantification; Spongiform change; Transmissible spongiform encephalopathy

Indexed keywords

PRION PROTEIN;

ARTICLE; ASTROCYTE; BRAIN SPONGIOSIS; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREUTZFELDT JAKOB DISEASE; GLIOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MICROSCOPY; NERVE CELL; NEUROPATHOLOGY; PRION DISEASE; PRIORITY JOURNAL; PUTAMEN; QUANTITATIVE ANALYSIS;

EID: 1542297689     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/63.3.193     Document Type: Article

References (45)

1. Collins S, McLean CA, Masters CL. Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia and kuru: A review of these less common human transmissible spongiform encephalopathies. J Clin Neurosci 2001;8:387-97
2. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982;216:136-44
3. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-33
4. Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996;39:767-85
5. Budka H, Aguzzi A, Brown P, et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (Prion diseases). Brain Pathol 1995;5: 459-66
6. Bell JE, Ironside JW. Neuropathology of spongiform encephalopathies in humans. Br Med Bull 1993;49:738-77
7. Fraser H, Dickinson AG. The sequential development of the brain lesions of scrapie in three strains of mice. J Comp Path 1968;78: 301-11
8. Sutherland K, MacDonald ST, Ironside JW. Quantification and analysis of neuropathological features of Creutzfeldt-Jakob disease. J Neurosci Methods 1996;64:123-32
9. Warren MA. Simple morphometry of the nervous system. In: Stewert MA, ed. Quantitative methods in neuroanatomy. New York: John Wiley & Sons, 1992:211-47
10. Sutherland K, Ironside JW. Novel application of image analysis to the detection of spongiform change. Anal Quant Cytol Histol 1994; 16:430-34
11. Privat N, Sazdovitch V, Seilhean D, LaPlanche JL, Hauw JJ. PrP immunohistochemistry: Different protocols, including a procedure for long formalin fixation, and a proposed schematic classification for deposits in sporadic Creutzfeldt-Jakob disease. Microsc Res Tech 2000;50:26-31
12. Madec JY, Groschup MH, Buschmann A, Belli P, Calavas D, Baron T. Sensitivity of the western blot detection of prion protein PrPres in natural sheep scrapie. J Virol Methods 1998;75:169-77
13. Laplanche JL, El Hachimi KH, Durieux I, et al. Prominent psychiatric features and early onset in an inherited prion disease with a new insertional mutation in the prion protein gene. Brain 1999;122: 2375-86
14. Manlow A, Munoz DG. A non-toxic method for demonstration of gliosis. J Neuropathol Exp Neurol 1992;51:298-302
15. Masters CL, Richardson EP Jr. Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 1978;101:333-44
16. Beck E, Daniel PM, Davey AJ, Gajdusek DC, Gibbs CJ Jr. The pathogenesis of transmissible spongiform encephalopathy: An ultrastructural study. Brain 1982;105:755-86
17. Chou SM, Payne WN, Gibbs CJ Jr, Gajdusek DC. Transmission and scanning electron microscopy of spongiform change in Creutzfeldt-Jakob disease. Brain 1980;103:885-904
18. Lampert PW, Gajdusek DC, Gibbs CJ Jr. Subacute spongiform virus encephalopathies. Scrapie, kuru and Creutzfeldt-Jakob disease: A review. Am J Pathol 1972;68:626-52
19. Goutieres F, Aicardi J. Acute neurological dysfunction associated with destructive lesions of the basal ganglia in children. Ann Neurol 1982;12:328-32
20. Leuzzi V, Bertini E, De Negri AM, Gallucci M, Garavaglia B. Bilateral striatal necrosis, dystonia and optic atrophy in two siblings. J Neurol Neurosurg Psychiatry 1992;55:16-19
21. Salazar AM, Masters CL, Gajdusek DC, Gibbs CJ Jr. Syndromes of amyotrophic lateral sclerosis and dementia: Relation to transmissible Creutzfeldt-Jakob disease. Ann Neurol 1983;14:17-26
22. Del Ser T, Hachinski V, Merskey H, Munoz DG. Clinical and pathologic features of two groups of patients with dementia with Lewy bodies: Effect of coexisting Alzheimer-type lesion load. Alzheimer Dis Assoc Disor 2001;15:31-44
23. Saito Y, Nakahara K, Yamanouchi H, Murayama S. Severe involvement of ambient gyrus in dementia with grains. J Neuropathol Exp Neurol 2002;61:789-96
24. Wilson CM, Grace GM, Munoz DG, He BP, Strong MJ. Cognitive impairment in sporadic ALS: A pathologic continuum underlying a multisystem disorder. Neurology 2001;57:651-57
25. Smith TW, Anwer U, DeGirolami U, Drachman DA. Vacuolar change in Alzheimer's disease. Arch Neurol 1987;44:1225-28
26. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: A clinical and pathological entity. Neurology 1990;40:1-8
27. Wester K, Wahlund E, Sundström C, et al. Paraffin section storage and immunohistochemistry. Appl Immunohistochem Mol Morphol 2000;8:61-70
28. Sutherland K, Ironside JW. Quantifying spongiform change in the brain by image analysis. European Microscopy and Analysis 1996; 21-22
29. Van Eitzen U, Egensperger R, Kosel S, et al. Microglia and the development of spongiform change in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 1998;57:246-56
30. Van Everbroeck B, Dewulf E, Pals P, Lubke U, Martin JJ, Cras P. The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease. Neurobiol Aging 2002;23:59-64
31. Rezaie P, Lantos PL. Microglia and the pathogenesis of spongiform encephalopathies. Brain Res Brain Res Rev 2001;35:55-72
32. Laszlo L, Lowe J, Self T, et al. Lysosomes as key organelles in the pathogenesis of prion encephalopathies. J Pathol 1992;166:333-41
33. Singh N, Gu Y, Bose S, Kalepu S, Mishra RS, Verghese S. Prion peptide 106-126 as a model for prion replication and neurotoxicity. Front Biosci 2002;7:60-71
34. Armstrong RA, Cairns NJ, Lantos PL. Quantification of the vacuolation (spongiform change) and prion protein deposition in 11 patients with sporadic Creutzfeldt-Jakob disease. Acta Neuropathol 2001;102:591-96
35. Armstrong RA, Cairns NJ, Ironside JW, Lantos PL. Quantification of vacuolation ("spongiform change"), surviving neurones and prion protein deposition in eleven cases of variant Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 2002;28:129-35
36. Gray F, Chretien F, Cesaro P, et al. Creutzfeldt-Jakob disease and cerebral amyloid angiopathy. Acta Neuropathol 1994;88:106-11
37. MacDonald ST, Sutherland K, Ironside JW. Prion protein genotype and pathological phenotype studies in sporadic Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 1996;22:285-92
38. Armstrong RA, Cairns NJ, Lantos PL. The spatial pattern of the vacuolation in patients with sporadic Creutzfeldt-Jakob disease. Neurosci Lett 2000;281:187-90
39. Tranchant C, Geranton L, Guiraud-Chaumeil C, Mohr M, Warter JM. Basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Neurology 1999;52:1244-49
40. Kovacs GG, Head MW, Bunn T, Laszlo L, Will RG, Ironside JW. Clinicopathological phenotype of codon 129 valine homozygote sporadic Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 2000;26:463-72
41. Kovàcs GG, Head MW, Hegyi I, et al. Immunohistochemistry for the prion protein: Comparison of different monoclonal antibodies in human prion disease subtypes. Brain Pathol 2002;12:1-11
42. Gonzàlez L, Martin S, Begara-McGorum I, et al. Effects of agent strain and host genotype on PrP accumulation in the brain of sheep naturally and experimentally affected with scrapie. J Comp Path 2002;126:17-29
43. Gonzàlez L, Martin S, Jeffrey M. Distinct profiles of PrP(d) immunoreactivity in the brain of scrapie- and BSE-infected sheep: Implications for differential cell targeting and PrP processing. J Gen Virol 2003;84:1339-50
44. Puoti G, Giaccone G, Rossi G, Canciani B, Bugiani O, Tagliavini F. Sporadic Creutzfeldt-Jakob disease: Co-occurrence of different types of PrP(Sc) in the same brain. Neurology 1999;53:2173-76
45. Bruce ME, Fraser H, McBride PA, Scott JR, Dickinson AG. The basis of strain variation in scrapie. In: Prusiner SB, Collinge J, Powell J, Anderton B, eds. Prion diseases of humans and animals. Chichester, UK: Ellis Horwood, 1992:497-508